American ginseng could inhibit colon cancer development

HPLC, UHPLC

American ginseng could inhibit colon cancer development

10 Nov, 2011

Published over 14 years ago. See the latest and most current information on HPLC, UHPLC.

A study has been conducted to determine if American ginseng could be used to inhibit the development of colon cancer in people who consume a western diet.

The research aimed to decipher if ginseng could inhibit western diet promoted colonic tumorigenesis and if compound K, a microbial metabolite of ginseng, could suppress colon cancer xenograft growth.

Mice were initiated with azoxymethane (AOM) and were fed a western diet, containing 20 per cent fat, or a western diet supplemented with 250-ppm ginseng.

After one week, the mice received 2.5 per cent dextran sulphate sodium (DSS) for five days and were sacrificed 12 weeks after AOM introduction.

Tumours were harvested a cell proliferation measured by Ki67 staining and apoptosis by TUNEL assay.

Anti-tumour effects of intraperitoneal compound K were examined using a tumour xenograft model and compound K absorption measured following oral ginseng gavage by UPLC-mass spectrometry.

Researchers found that ginseng significantly inhibited colonic inflammation, tumorigenesis and concomitantly reduced proliferation and increased apoptosis.

Posted by Neil Clark

Latest News

Explore Our Other Sites

Labmate Online
Repurposed drug offers new route to faster tuberculosis treatment
Explore more Arrow
Envirotech Online
Exhibitor registration opens for 2027 occupational safety and health trade fair in Düsseldorf
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
UK refining capacity falls to four plants after a second unplanned closure
Explore more Arrow